生物类似药研发与评价技术指导原则(试行)

2019-10-31 国家药品监督管理局药品审评中心(CDE)

生物类似药研发与评价技术指导原则(试行)

中文标题:

生物类似药研发与评价技术指导原则(试行)

发布日期:

2019-10-31

简要介绍:

生物类似药研发与评价技术指导原则(试行)

相关资料下载:
[AttachmentFileName(sort=100, fileName=生物类似药研发与评价技术指导原则(试行))] GetToolGuiderByIdResponse(projectId=1, id=53fbd1c0018208da, title=生物类似药研发与评价技术指导原则(试行), enTitle=, guiderFrom=, authorId=null, author=, summary=生物类似药研发与评价技术指导原则(试行), cover=, journalId=null, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Thu Oct 31 06:33:02 CST 2019, originalUrl=, linkOutUrl=, content=生物类似药研发与评价技术指导原则(试行), tagList=[TagDto(tagId=25222, tagName=生物类似药)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2377, appHits=17, showAppHits=0, pcHits=1237, showPcHits=2146, likes=32, shares=0, comments=2, approvalStatus=1, publishedTime=Thu Oct 31 06:33:02 CST 2019, publishedTimeString=2019-10-31, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Thu Oct 31 06:33:02 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 22:28:18 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=生物类似药研发与评价技术指导原则(试行))])
生物类似药研发与评价技术指导原则(试行)
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=890845, encodeId=6879890845c4, content=打不开, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5ef92129227, createdName=1361fc5d0em, createdTime=Fri Oct 09 18:19:39 CST 2020, time=2020-10-09, status=1, ipAttribution=)]
    2020-10-09 1361fc5d0em

    打不开

    0